These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 39387233)

  • 1. Evaluating the breadth of nucleic acid-based payloads delivered in lipid nanoparticles to establish fundamental differences in development.
    Li J; Foged C
    Expert Opin Drug Deliv; 2024 Oct; 21(10):1441-1461. PubMed ID: 39387233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01.
    Ashizawa AT; Cortes J
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1107-20. PubMed ID: 25539721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid.
    Jia Y; Wang X; Li L; Li F; Zhang J; Liang XJ
    Adv Mater; 2024 Jan; 36(4):e2305300. PubMed ID: 37547955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vast majority of nucleic acid-loaded lipid nanoparticles contain cargo.
    Münter R; Larsen JB; Andresen TL
    J Colloid Interface Sci; 2024 Nov; 674():139-144. PubMed ID: 38925059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies - challenges and opportunities.
    Simonsen JB
    J Control Release; 2024 Jun; 370():763-772. PubMed ID: 38621638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based nucleic acid therapeutics with in vivo efficacy.
    Sufian MA; Ilies MA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1856. PubMed ID: 36180107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 60-year evolution of lipid nanoparticles for nucleic acid delivery.
    Cullis PR; Felgner PL
    Nat Rev Drug Discov; 2024 Sep; 23(9):709-722. PubMed ID: 38965378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of lipid components in lipid nanoparticles for vaccines and gene therapy.
    Hald Albertsen C; Kulkarni JA; Witzigmann D; Lind M; Petersson K; Simonsen JB
    Adv Drug Deliv Rev; 2022 Sep; 188():114416. PubMed ID: 35787388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Nanoparticles for Nucleic Acid Delivery Beyond the Liver.
    Saber N; Senti ME; Schiffelers RM
    Hum Gene Ther; 2024 Sep; 35(17-18):617-627. PubMed ID: 39139067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuning the Immunostimulation Properties of Cationic Lipid Nanocarriers for Nucleic Acid Delivery.
    Dey AK; Nougarède A; Clément F; Fournier C; Jouvin-Marche E; Escudé M; Jary D; Navarro FP; Marche PN
    Front Immunol; 2021; 12():722411. PubMed ID: 34497612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
    Tenchov R; Bird R; Curtze AE; Zhou Q
    ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
    Xu L; Anchordoquy T
    J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
    Cheng X; Lee RJ
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of targeted delivery systems for nucleic acid drugs.
    Mahato RI; Takakura Y; Hashida M
    J Drug Target; 1997; 4(6):337-57. PubMed ID: 9239575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Lipid Nanoparticles for the Delivery of Macromolecules Based on the Molecular Design of pH-Sensitive Cationic Lipids.
    Sato Y
    Chem Pharm Bull (Tokyo); 2021; 69(12):1141-1159. PubMed ID: 34853281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-based nanoparticle formulations for small molecules and RNA drugs.
    Ickenstein LM; Garidel P
    Expert Opin Drug Deliv; 2019 Nov; 16(11):1205-1226. PubMed ID: 31530041
    [No Abstract]   [Full Text] [Related]  

  • 18. Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.
    Shi B; Abrams M
    J Histochem Cytochem; 2013 Jun; 61(6):407-20. PubMed ID: 23504369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
    Francia V; Schiffelers RM; Cullis PR; Witzigmann D
    Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-Bio Interactions: Exploring the Biological Behavior and the Fate of Lipid-Based Gene Delivery Systems.
    Kimura S; Harashima H
    BioDrugs; 2024 Mar; 38(2):259-273. PubMed ID: 38345754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.